Literature DB >> 16583131

Cumene peroxide and Fe(2+)-ascorbate-induced lipid peroxidation and effect of phosphoglucose isomerase.

Z S Agadjanyan1, S F Dugin, L F Dmitriev.   

Abstract

Malondialdehyde (MDA) is one of cytotoxic aldehydes produced in cells as a result of lipid peroxidation and further MDA metabolism in cytoplasm is not known. In our experiments the liver fraction 10,000 g containing phosphoglucose isomerase and enzymes of the glyoxalase system was used and obtained experimental data shows that in this fraction there is an aggregate of reactions taking place both in membranes (lipid peroxidation) and outside membranes. MDA accumulation is relatively slow because MDA is a substrate of aldehyde isomerase (MDA <--> methylglyoxal). The well known enzyme phosphoglucose isomerase acts as an aldehyde isomerase (Michaelis constant for this enzyme Km = 133 +/- 8 microM). MDA conversion to methylglyoxal and further to neutral product D-lactate (with GSH as a cofactor) occurs in cytoplasm and D-lactate should be regarded as the end product of two different parametabolic reactions: lipid peroxidation or protein glycation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583131     DOI: 10.1007/s11010-006-9146-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  12 in total

Review 1.  Mechanisms and consequences of lipid peroxidation in biological systems.

Authors:  A Sevanian; P Hochstein
Journal:  Annu Rev Nutr       Date:  1985       Impact factor: 11.848

2.  Role of endogenous and exogenous antioxidants in the defence against functional damage and lipid peroxidation in rat liver mitochondria.

Authors:  W Augustin; I Wiswedel; H Noack; T Reinheckel; O Reichelt
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

3.  Comparative studies on different methods of malonaldehyde determination.

Authors:  R P Bird; H H Draper
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Glyoxalase I from mouse liver.

Authors:  B Oray; S J Norton
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

Review 5.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

Authors:  Daniele Del Rio; Amanda J Stewart; Nicoletta Pellegrini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-08       Impact factor: 4.222

6.  High-performance liquid chromatographic-fluorometric determination of glyoxal, methylglyoxal, and diacetyl in urine by prederivatization to pteridinic rings.

Authors:  A Espinosa-Mansilla; I Durán-Merás; F Salinas
Journal:  Anal Biochem       Date:  1998-01-15       Impact factor: 3.365

7.  Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase.

Authors:  David L Vander Jagt; Lucy A Hunsaker
Journal:  Chem Biol Interact       Date:  2003-02-01       Impact factor: 5.192

8.  Interaction of tocopherol with peroxyl radicals does not lead to the formation of lipid hydroperoxides in liposomes.

Authors:  L F Dmitriev; M V Ivanova; V Z Lankin
Journal:  Chem Phys Lipids       Date:  1994-01       Impact factor: 3.329

9.  Fluorimetric assay of D-lactate.

Authors:  A C McLellan; S A Phillips; P J Thornalley
Journal:  Anal Biochem       Date:  1992-10       Impact factor: 3.365

10.  Metabolism of malonaldehyde in vivo and in vitro.

Authors:  G M Siu; H H Draper
Journal:  Lipids       Date:  1982-05       Impact factor: 1.880

View more
  2 in total

Review 1.  Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease.

Authors:  Leonid F Dmitriev
Journal:  Neurochem Res       Date:  2007-05-31       Impact factor: 3.996

2.  An anthracenecarboximide-guanidine fluorescent probe for selective detection of glyoxals under weak acidic conditions.

Authors:  Junwei Chen; Yuna Lin; Wanjin Xing; Xingchen Zhang; Huan Xu; Wei Wang; Kaiyan Lou
Journal:  RSC Adv       Date:  2022-03-25       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.